• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 - 2019年北非和中东地区代谢风险因素负担:全球疾病负担研究的结果

The burden of metabolic risk factors in North Africa and the Middle East, 1990-2019: findings from the Global Burden of Disease Study.

作者信息

Malekpour Mohammad-Reza, Abbasi-Kangevari Mohsen, Ghamari Seyyed-Hadi, Khanali Javad, Heidari-Foroozan Mahsa, Moghaddam Sahar Saeedi, Azangou-Khyavy Mohammadreza, Rezazadeh-Khadem Sahba, Rezaei Negar, Shobeiri Parnian, Esfahani Zahra, Rezaei Nazila, Mokdad Ali H, Naghavi Mohsen, Larijani Bagher, Farzadfar Farshad

机构信息

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Kiel Institute for the World Economy, Kiel, Germany.

出版信息

EClinicalMedicine. 2023 Jun 2;60:102022. doi: 10.1016/j.eclinm.2023.102022. eCollection 2023 Jun.

DOI:10.1016/j.eclinm.2023.102022
PMID:37287869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10242634/
Abstract

BACKGROUND

The objective of this study is to investigate the trends of exposure and burden attributable to the four main metabolic risk factors, including high systolic blood pressure (SBP), high fasting plasma glucose (FPG), high body-mass index (BMI), and high low-density lipoproteins cholesterol (LDL) in North Africa and the Middle East from 1990 to 2019.

METHODS

The data were retrieved from Global Burden of Disease Study 2019. Summary exposure value (SEV) was used for risk factor exposure. Burden attributable to each risk factor was incorporated in the population attributable fraction to estimate the total attributable deaths and disability-adjusted life-years (DALYs).

FINDINGS

While age-standardized death rate (ASDR) attributable to high-LDL and high-SBP decreased by 26.5% (18.6-35.2) and 23.4% (15.9-31.5) over 1990-2019, respectively, high-BMI with 5.1% (-9.0-25.9) and high-FPG with 21.4% (7.0-37.4) change, grew in ASDR. Moreover, age-standardized DALY rate attributed to high-LDL and high-SBP declined by 30.2% (20.9-39.0) and 25.2% (16.8-33.9), respectively. The attributable age-standardized DALY rate of high-BMI with 8.3% (-6.5-28.8) and high-FPG with 27.0% (14.3-40.8) increase, had a growing trend. Age-standardized SEVs of high-FPG, high-BMI, high-SBP, and high-LDL increased by 92.4% (82.8-103.3), 76.0% (58.9-99.3), 10.4% (3.8-18.0), and 5.5% (4.3-7.1), respectively.

INTERPRETATION

The burden attributed to high-SBP and high-LDL decreased during the 1990-2019 period in the region, while the attributable burden of high-FPG and high-BMI increased. Alarmingly, exposure to all four risk factors increased in the past three decades. There has been significant heterogeneity among the countries in the region regarding the trends of exposure and attributable burden. Urgent action is required at the individual, community, and national levels in terms of introducing effective strategies for prevention and treatment that account for local and socioeconomic factors.

FUNDING

Bill & Melinda Gates Foundation.

摘要

背景

本研究的目的是调查1990年至2019年期间北非和中东地区四种主要代谢风险因素(包括收缩压升高、空腹血糖升高、体重指数升高和低密度脂蛋白胆固醇升高)的暴露趋势和归因负担。

方法

数据取自《2019年全球疾病负担研究》。使用汇总暴露值(SEV)来衡量风险因素暴露情况。将每个风险因素的负担纳入人群归因分数,以估计总归因死亡数和伤残调整生命年(DALY)。

研究结果

1990年至2019年期间,归因于高LDL和高SBP的年龄标准化死亡率(ASDR)分别下降了26.5%(18.6 - 35.2)和23.4%(15.9 - 31.5),而高BMI的ASDR变化为5.1%(-9.0 - 25.9),高FPG的ASDR变化为21.4%(7.0 - 37.4),呈上升趋势。此外,归因于高LDL和高SBP的年龄标准化DALY率分别下降了30.2%(20.9 - 39.0)和25.2%(16.8 - 33.9)。高BMI的归因年龄标准化DALY率上升了8.3%(-6.5 - 28.8),高FPG的上升了27.0%(14.3 - 40.8),呈上升趋势。高FPG、高BMI、高SBP和高LDL的年龄标准化SEV分别上升了92.4%(82.8 - 103.3)、76.0%(58.9 - 99.3)、10.4%(3.8 - 18.0)和5.5%(4.3 - 7.1)。

解读

1990年至2019年期间,该地区归因于高SBP和高LDL的负担有所下降,而高FPG和高BMI的归因负担有所增加。令人担忧的是,在过去三十年中,所有这四种风险因素的暴露都有所增加。该地区各国在暴露趋势和归因负担方面存在显著差异。需要在个人、社区和国家层面采取紧急行动,制定考虑当地和社会经济因素的有效预防和治疗策略。

资金来源

比尔及梅琳达·盖茨基金会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/2fd92509a5b8/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/9860e66faafc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/7a9920ade93e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/b8320c7da477/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/09be3dc6cb5f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/50dae4bba24f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/26d0aff0d682/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/2fd92509a5b8/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/9860e66faafc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/7a9920ade93e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/b8320c7da477/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/09be3dc6cb5f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/50dae4bba24f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/26d0aff0d682/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f73f/10242634/2fd92509a5b8/gr7.jpg

相似文献

1
The burden of metabolic risk factors in North Africa and the Middle East, 1990-2019: findings from the Global Burden of Disease Study.1990 - 2019年北非和中东地区代谢风险因素负担:全球疾病负担研究的结果
EClinicalMedicine. 2023 Jun 2;60:102022. doi: 10.1016/j.eclinm.2023.102022. eCollection 2023 Jun.
2
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病负担研究 2021 年在 204 个国家和地区、811 个次国家级地点对 88 种风险因素的全球负担和证据强度:系统分析。
Lancet. 2024 May 18;403(10440):2162-2203. doi: 10.1016/S0140-6736(24)00933-4.
3
Effect of air pollution on disease burden, mortality, and life expectancy in North Africa and the Middle East: a systematic analysis for the Global Burden of Disease Study 2019.空气污染对北非和中东地区疾病负担、死亡率和预期寿命的影响:2019 年全球疾病负担研究的系统分析。
Lancet Planet Health. 2023 May;7(5):e358-e369. doi: 10.1016/S2542-5196(23)00053-0.
4
Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.全球 188 个国家 1990-2013 年卒中负担和风险因素:2013 年全球疾病负担研究的系统分析。
Lancet Neurol. 2016 Aug;15(9):913-924. doi: 10.1016/S1474-4422(16)30073-4. Epub 2016 Jun 9.
5
Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990-2019.归因于 1990-2019 年中东和北非地区空腹血糖升高的癌症负担。
Cancer Med. 2023 Apr;12(8):10031-10044. doi: 10.1002/cam4.5743. Epub 2023 Mar 23.
6
Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019.归因于代谢风险因素的伊朗负担在国家和次国家层面上,1990 年至 2019 年。
Front Public Health. 2023 Jun 1;11:1149719. doi: 10.3389/fpubh.2023.1149719. eCollection 2023.
7
The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.2019 年全球 195 个国家和地区因超重导致的疾病负担:基于全球疾病负担研究的分析。
PLoS Med. 2020 Jul 28;17(7):e1003198. doi: 10.1371/journal.pmed.1003198. eCollection 2020 Jul.
8
Historical trends of breast cancer burden attributable to metabolic factors among Chinese women, 1990-2019: A population-based epidemiological study.中国女性归因于代谢因素的乳腺癌负担的历史趋势,1990-2019:基于人群的流行病学研究。
Thorac Cancer. 2024 Jun;15(16):1279-1286. doi: 10.1111/1759-7714.15316. Epub 2024 Apr 25.
9
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.21 个地区 1990-2010 年 67 种致病因素和致病因素群导致的疾病和伤害负担的比较风险评估:全球疾病负担研究 2010 系统分析。
Lancet. 2012 Dec 15;380(9859):2224-60. doi: 10.1016/S0140-6736(12)61766-8.
10
The Global Burden of Diseases attributed to high low-density lipoprotein cholesterol from 1990 to 2019.1990 年至 2019 年归因于高低密度脂蛋白胆固醇的全球疾病负担。
Front Public Health. 2022 Aug 16;10:891929. doi: 10.3389/fpubh.2022.891929. eCollection 2022.

引用本文的文献

1
Burden of disease using disability adjusted life years in the Middle East and North Africa (MENA) region: protocol of a systematic review.中东和北非(MENA)地区使用伤残调整生命年的疾病负担:一项系统评价方案
BMJ Open. 2025 Jun 24;15(6):e096214. doi: 10.1136/bmjopen-2024-096214.
2
Demographic and metabolic risk factors for non-communicable diseases in Iran: insights from a prospective cohort study.伊朗非传染性疾病的人口统计学和代谢危险因素:一项前瞻性队列研究的见解
J Diabetes Metab Disord. 2025 Jun 11;24(2):147. doi: 10.1007/s40200-025-01645-1. eCollection 2025 Dec.
3
Temporal trends in cardiovascular disease risk factors attributed burden in Iran, 1990-2021.

本文引用的文献

1
Quality and cost of healthcare services in patients with diabetes in Iran: Results of a nationwide short-term longitudinal survey.伊朗糖尿病患者的医疗服务质量和成本:一项全国性短期纵向调查的结果。
Front Endocrinol (Lausanne). 2023 Mar 16;14:1099464. doi: 10.3389/fendo.2023.1099464. eCollection 2023.
2
Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients.抗糖尿病药物治疗的依从性与老年虚弱患者致死事件的减少。
Cardiovasc Diabetol. 2023 Mar 10;22(1):53. doi: 10.1186/s12933-023-01786-8.
3
The global burden of metabolic disease: Data from 2000 to 2019.
1990 - 2021年伊朗心血管疾病风险因素所致负担的时间趋势。
Sci Rep. 2025 Apr 24;15(1):14279. doi: 10.1038/s41598-025-97481-7.
4
Dynamic Status of Systemic Immune Inflammation Index Is Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: An Evidence From a Ten-Year Prospective Longitudinal Cohort Study.全身免疫炎症指数的动态状态与代谢功能障碍相关脂肪性肝病有关:一项十年前瞻性纵向队列研究的证据
J Inflamm Res. 2025 Apr 1;18:4595-4606. doi: 10.2147/JIR.S509814. eCollection 2025.
5
Burden of cardiometabolic disease attributable to sugar sweetened beverages consumption in North Africa and the Middle East from 1990 to 2021.1990年至2021年期间,北非和中东地区因饮用含糖饮料导致的心血管代谢疾病负担
J Diabetes Metab Disord. 2025 Feb 12;24(1):66. doi: 10.1007/s40200-025-01578-9. eCollection 2025 Jun.
6
Incidence trends and specific risk factors of ischemic heart disease and stroke: An ecological analysis based on the Global Burden of Disease 2019.缺血性心脏病和中风的发病率趋势及特定风险因素:基于《2019年全球疾病负担》的生态分析
PLOS Glob Public Health. 2024 Nov 20;4(11):e0003920. doi: 10.1371/journal.pgph.0003920. eCollection 2024.
7
Causes of Hospitalization in Patients With Cardiorenal Syndrome Across the Spectrum of Ejection Fraction.射血分数范围内的心肾综合征患者的住院原因
Int J Heart Fail. 2024 Jun 25;6(3):137-139. doi: 10.36628/ijhf.2023.0065. eCollection 2024 Jul.
8
Trends and findings of lipoprotein(a) testing and associated cardiovascular disease profiles: a large single-center study from the Middle East-Gulf region.脂蛋白(a)检测的趋势与结果及相关心血管疾病概况:一项来自中东-海湾地区的大型单中心研究
Front Cardiovasc Med. 2024 Jul 9;11:1439013. doi: 10.3389/fcvm.2024.1439013. eCollection 2024.
9
Burden of diseases due to high systolic blood pressure in the Middle East and North Africa region from 1990 to 2019.1990年至2019年中东和北非地区因收缩压升高导致的疾病负担。
Sci Rep. 2024 Jun 13;14(1):13617. doi: 10.1038/s41598-024-64563-x.
10
The impact of ketogenic diet on some metabolic and non-metabolic diseases: Evidence from human and animal model experiments.生酮饮食对某些代谢性和非代谢性疾病的影响:来自人体和动物模型实验的证据。
Food Sci Nutr. 2024 Jan 8;12(3):1444-1464. doi: 10.1002/fsn3.3873. eCollection 2024 Mar.
全球代谢性疾病负担:2000 年至 2019 年的数据。
Cell Metab. 2023 Mar 7;35(3):414-428.e3. doi: 10.1016/j.cmet.2023.02.003.
4
Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies.降脂治疗随机试验中安慰剂效应和反安慰剂效应的荟萃分析。
Eur Heart J Qual Care Clin Outcomes. 2023 Aug 7;9(5):511-519. doi: 10.1093/ehjqcco/qcac060.
5
Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019.伊朗的卫生系统绩效:2019 年全球疾病负担研究的系统分析。
Lancet. 2022 Apr 23;399(10335):1625-1645. doi: 10.1016/S0140-6736(21)02751-3. Epub 2022 Apr 6.
6
Statins: are they appropriate for all patients?他汀类药物:它们适用于所有患者吗?
Lancet Glob Health. 2022 Mar;10(3):e305-e306. doi: 10.1016/S2214-109X(21)00572-6.
7
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.降压药物治疗用于不同血压水平的心血管疾病一级和二级预防:一项个体参与者水平数据的荟萃分析。
Lancet. 2021 May 1;397(10285):1625-1636. doi: 10.1016/S0140-6736(21)00590-0.
8
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.
9
Patterns of Obesity and Overweight in the Iranian Population: Findings of STEPs 2016.伊朗人群的肥胖和超重模式:2016 年 STEPs 研究结果。
Front Endocrinol (Lausanne). 2020 Feb 26;11:42. doi: 10.3389/fendo.2020.00042. eCollection 2020.
10
Metabolic health in the Middle East and north Africa.中东和北非的代谢健康。
Lancet Diabetes Endocrinol. 2019 Nov;7(11):866-879. doi: 10.1016/S2213-8587(19)30179-2. Epub 2019 Aug 14.